Callan Family Office LLC Makes New Investment in Synopsys, Inc. $SNPS

Key Points

• Callan Family Office purchased 7,088 Synopsys shares worth approximately $3.16 million in the second quarter. Institutional investors collectively own 85.47% of the company.
• Synopsys exceeded quarterly expectations, reporting $3.35 in EPS versus the $3.15 consensus and $2.28 billion in revenue, up 41.9% year over year.
• Analysts maintain a generally positive outlook, with a “Moderate Buy” consensus rating and an average price target of $563.59, although CEO and CFO share sales were disclosed under pre-arranged plans.

Callan Family Office LLC purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 7,088 shares of the semiconductor company's stock, valued at approximately $3,162,000.

Several other large investors also recently made changes to their positions in the business. Sankala Group LLC bought a new stake in shares of Synopsys in the 4th quarter worth approximately $25,000. Elevation Wealth Partners LLC lifted its stake in Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 27 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in Synopsys during the fourth quarter worth approximately $28,000. IMG Wealth Management Inc. bought a new stake in Synopsys during the second quarter worth approximately $28,000. Finally, Atlas Capital Advisors Inc. bought a new stake in Synopsys during the fourth quarter worth approximately $32,000. Institutional investors own 85.47% of the company's stock.

Synopsys Stock Performance

Shares of SNPS opened at $397.87 on Friday. The company has a 50-day moving average of $419.73 and a two-hundred day moving average of $440.22. The stock has a market cap of $76.18 billion, a price-to-earnings ratio of 92.10, a PEG ratio of 2.34 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. Synopsys, Inc. has a one year low of $366.00 and a one year high of $615.79.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. During the same quarter in the previous year, the business earned $3.67 earnings per share. The firm's revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities research analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Insider Buying and Selling at Synopsys

In other news, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company's stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on SNPS shares. Bank of America upped their price target on Synopsys from $515.00 to $600.00 and gave the company a "buy" rating in a report on Thursday, May 28th. Stifel Nicolaus raised their price objective on Synopsys from $550.00 to $600.00 and gave the stock a "buy" rating in a research note on Thursday, May 28th. Morgan Stanley reduced their price objective on Synopsys from $525.00 to $500.00 and set an "equal weight" rating for the company in a research note on Wednesday. Benchmark restated a "buy" rating on shares of Synopsys in a report on Wednesday. Finally, Berenberg Bank set a $633.00 target price on Synopsys in a research report on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $563.59.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source